Does PEGINTERFERON ALFA-2B Cause Hepatocellular carcinoma? 93 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 93 reports of Hepatocellular carcinoma have been filed in association with PEGINTERFERON ALFA-2B. This represents 2.2% of all adverse event reports for PEGINTERFERON ALFA-2B.
93
Reports of Hepatocellular carcinoma with PEGINTERFERON ALFA-2B
2.2%
of all PEGINTERFERON ALFA-2B reports
15
Deaths
33
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From PEGINTERFERON ALFA-2B?
Of the 93 reports, 15 (16.1%) resulted in death, 33 (35.5%) required hospitalization, and 1 (1.1%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGINTERFERON ALFA-2B. However, 93 reports have been filed with the FAERS database.
What Other Side Effects Does PEGINTERFERON ALFA-2B Cause?
Anaemia (804)
Platelet count decreased (593)
Pyrexia (440)
White blood cell count decreased (420)
Haemoglobin decreased (281)
Neutrophil count decreased (272)
Nausea (269)
Rash (269)
Fatigue (245)
Decreased appetite (224)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which PEGINTERFERON ALFA-2B Alternatives Have Lower Hepatocellular carcinoma Risk?
PEGINTERFERON ALFA-2B vs PEGINTERFERON BETA-1A
PEGINTERFERON ALFA-2B vs PEGINTRON
PEGINTERFERON ALFA-2B vs PEGLOTICASE
PEGINTERFERON ALFA-2B vs PEGUNIGALSIDASE ALFA-IWXJ
PEGINTERFERON ALFA-2B vs PEGVALIASE-PQPZ